Literature DB >> 6511865

Elevated concentrations of leukotriene D4 in pulmonary edema fluid of patients with the adult respiratory distress syndrome.

M A Matthay, W L Eschenbacher, E J Goetzl.   

Abstract

The possible contribution of metabolites of arachidonic acid to the increased permeability of the alveolar-capillary barrier in the adult respiratory distress syndrome was examined by quantifying the pulmonary edema fluid concentrations of lipoxygenase and cyclooxygenase products. The concentration of leukotriene D4 in pulmonary edema fluid of 10 patients with the adult respiratory distress syndrome (18.5 +/- 6.8 pmol/ml; mean +/- SD), assessed by specific radioimmunoassay after isolation of the mediator, was significantly higher (P less than 0.001) than that of five patients with cardiogenic pulmonary edema (4.4 +/- 1.1 pmol/ml). The concentrations of leukotrienes B4 and C4, prostaglandin E2, and thromboxane B2 in edema fluid were not significantly different in the adult respiratory distress syndrome patients than in the other subjects with pulmonary edema. The edema fluid concentration of leukotriene D4 correlated with the ratio of edema fluid to plasma concentrations of albumin (r = 0.64). Leukotriene D4 thus may contribute to the permeability defect which allows an accumulation of protein-rich alveolar fluid in the adult respiratory distress syndrome.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6511865     DOI: 10.1007/bf00916578

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  22 in total

Review 1.  Trends in microvascular research. The microembolism syndrome.

Authors:  T Saldeen
Journal:  Microvasc Res       Date:  1976-03       Impact factor: 3.514

2.  Platelet-activating factor causes pulmonary vasoconstriction and edema via platelet-independent leukotriene formation.

Authors:  N F Voelkel; J Simpson; S Worthen; J T Reeves; P M Henson; R C Murphy
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1983

3.  Adult respiratory distress syndrome: risk with common predispositions.

Authors:  A A Fowler; R F Hamman; J T Good; K N Benson; M Baird; D J Eberle; T L Petty; T M Hyers
Journal:  Ann Intern Med       Date:  1983-05       Impact factor: 25.391

4.  Clinical predictors of the adult respiratory distress syndrome.

Authors:  P E Pepe; R T Potkin; D H Reus; L D Hudson; C J Carrico
Journal:  Am J Surg       Date:  1982-07       Impact factor: 2.565

5.  Documentation of pulmonary capillary permeability in the adult respiratory distress syndrome accompanying human sepsis.

Authors:  R R Anderson; R L Holliday; A A Driedger; M Lefcoe; B Reid; W J Sibbald
Journal:  Am Rev Respir Dis       Date:  1979-06

6.  Intravascular coagulation associated with the adult respiratory distress syndrome.

Authors:  R C Bone; P B Francis; A K Pierce
Journal:  Am J Med       Date:  1976-11       Impact factor: 4.965

7.  Corticosteroids inhibit complement-induced granulocyte aggregation. A possible mechanism for their efficacy in shock states.

Authors:  D E Hammerschmidt; J G White; P R Craddock; H S Jacob
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

8.  Functional and metabolic activity of granulocytes from patients with adult respiratory distress syndrome. Evidence for activated neutrophils in the pulmonary circulation.

Authors:  G A Zimmerman; A D Renzetti; H R Hill
Journal:  Am Rev Respir Dis       Date:  1983-03

9.  Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources.

Authors:  R A Lewis; K F Austen; J M Drazen; D A Clark; A Marfat; E J Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

10.  Stimulus specificity of the generation of leukotrienes by dog mastocytoma cells.

Authors:  E J Goetzl; M J Phillips; W M Gold
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  40 in total

Review 1.  Pulmonary diseases other than asthma as potential targets for antileukotriene therapy.

Authors:  M Peters-Golden
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

Review 2.  The measurement of leukotrienes in human fluids.

Authors:  J Y Westcott
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

Review 3.  The pulmonary physician and critical care. 4. A new look at the pulmonary circulation in acute lung injury.

Authors:  G A Fox; D G McCormack
Journal:  Thorax       Date:  1992-09       Impact factor: 9.139

Review 4.  Resolution of pulmonary edema. New insights.

Authors:  M A Matthay
Journal:  West J Med       Date:  1991-03

Review 5.  The adult respiratory distress syndrome. New insights into diagnosis, pathophysiology, and treatment.

Authors:  M A Matthay
Journal:  West J Med       Date:  1989-02

6.  Leukotrienes in acute lung injury: a potential therapeutic target?

Authors:  James A Frank; Michael A Matthay
Journal:  Am J Respir Crit Care Med       Date:  2005-08-01       Impact factor: 21.405

Review 7.  The mercurial nature of neutrophils: still an enigma in ARDS?

Authors:  Andrew E Williams; Rachel C Chambers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-12-06       Impact factor: 5.464

Review 8.  Contribution of neutrophils to acute lung injury.

Authors:  Jochen Grommes; Oliver Soehnlein
Journal:  Mol Med       Date:  2010-10-18       Impact factor: 6.354

Review 9.  Endothelial modification of pulmonary vascular tone.

Authors:  N P Curzen; K B Jourdan; J A Mitchell
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

10.  Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury.

Authors:  Jonathan A Kropski; Richard D Fremont; Carolyn S Calfee; Lorraine B Ware
Journal:  Chest       Date:  2009-02-02       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.